Market Scope
Monoclonal Antibody Custom Services Market Share is expected to reach USD 1,045.97 million by 2030 at a CAGR of 5.90% during the forecast period 2022-2030. We will provide COVID-19 impact analysis with the report, along with an in-depth review post the coronavirus disease outbreak.
Main Boosters and Restraints
Monoclonal antibodies make extensive use of adaptive immunity’s extremely evolved specificity to fight a disease. Monoclonal antibodies are utilized in the treatment of chronic and severe conditions such as systemic lupus erythematous, Crohn’s diseases, rheumatoid arthritis, osteoporosis, psoriasis, and certain types of cancer. These antibodies target the affected areas to get rid of the diseased cells to completely restore the immune system. Monoclonal antibody custom service can be described as the services that provide the options of the development of both mouse and rat hybridomas to produce custom monoclonal antibodies from recombinant protein antigens or synthesized peptide.
The market for monoclonal antibody custom service is primarily bolstered by the increasing cases of cancer and various chronic diseases along with the surge in R&D activities in the genomics field. A number of renowned firms are employing growth strategies such as acquisitions, mergers, regional expansion and partnerships to fortify their positions in the global market. Many of the players are also focused on developing and launching new and more advanced products in the market to remain ahead in the competitive landscape.
Segmental Analysis
The Monoclonal Antibody Custom Services Market Trends has been considered for type, application, and end user.
· The primary types mentioned in the study are rat custom monoclonal antibody, rat custom monoclonal antibody, and more.
· The key applications of monoclonal antibody Protein purification, therapeutic application, diagnostic application, and others, With the highest share of 9% in 2016, the protein purification segment is leading the global market.
· The end users analyzed in the report are pharmaceutical & biotechnology companies, research & academic laboratories, hospitals, and others.
Key Firms
The key Monoclonal Antibody Custom Services Market Players studied in the MRFR report are ProMab Biotechnologies Inc (US), GenScript (China), Abcam PLC (UK), Envigo (US), Thermo Fisher Scientific Inc. (US), Abnova Corporation (Taiwan), Creative-Biolabs (US), and more.
Regional Outlook
The Monoclonal Antibody Custom Services Market Outlook has been regionally segregated into Europe, the Americas, MEA or Middle East & Africa and Asia Pacific or APAC.
Over the coming years, there is a strong possibility that the American market can take the lead, as the region consist of a massive pool of patients that suffer from autoimmune & inflammatory diseases, cancer, and more, which bolsters the demand for monoclonal antibody custom services. The rising adoption of stressful lifestyle and the surge in government support in the form of substantial funds for research & development also benefit the American market. The United States is currently the frontrunner in the regional market, given the high number of cases of cancer in the country. In 2016, the National Cancer Institute confirmed that close to 1.6 million cancer cases were recorded in the US.
Europe can be the second biggest gainer in the monoclonal antibody custom service market, backed by the strong government support with respect to infection management and control, the increasing cases of lifestyle-based disorders and diseases, and the high spending on R&D activities for cancer by private firms.
APAC could secure the third place in the global market, thanks to the enormous population pool, growing prominence of various types of cancer and the fast-developing countries with improving healthcare infrastructure. Considerable growth of medical tourism also presents an attractive opportunity to the market players in the region. China is the most lucrative market for monoclonal antibody custom service in the region, having seized a share of 22% in 2016. The growing patient awareness with regard to the therapeutic use of mAbs has led to significant market growth in the country.
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
